Minoxidil sulphate
Minoxidil sulphate structure
|
Common Name | Minoxidil sulphate | ||
|---|---|---|---|---|
| CAS Number | 83701-22-8 | Molecular Weight | 289.311 | |
| Density | N/A | Boiling Point | 732ºC at 760 mmHg | |
| Molecular Formula | C9H15N5O4S | Melting Point | 175-180°C | |
| MSDS | Chinese USA | Flash Point | 396.5ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of Minoxidil sulphateMinoxidil sulfate, a potent and ATP-sensitive K+ channel opener, is the sulfated metabolite of minoxidil. Minoxidil sulfate is considered as a vasodilator to promote hair growth in vivo[1][3]. |
| Name | Minoxidil Sulfate |
|---|---|
| Synonym | More Synonyms |
| Description | Minoxidil sulfate, a potent and ATP-sensitive K+ channel opener, is the sulfated metabolite of minoxidil. Minoxidil sulfate is considered as a vasodilator to promote hair growth in vivo[1][3]. |
|---|---|
| Related Catalog | |
| Target |
IC50: K channel[2] |
| In Vitro | Minoxidil sulfate (1-100 μM; 2 hours) significantly reduces the permeability of bloode-brain tumor barrier (BTB) in a monolayer of RBMEC in a time-dependent manner, additionally,the effects of MS on transendothelial electrical resistance (TEER) is Transendothelial electrical resistance (TEER) at 2 h with high concentration[2]. Minoxidil sulfate (0-100 μM; 0-4 hours) increases the RhoA activation in brain tumor tissue by 1 h and the highest level appears at 2 h, it also significantly induces transient PKB phosphorylation at Ser-473, without affecting total PKB levels. Addiotionally, LY294002 partly prevents the phosphorylation of PKB induced by MS[2]. Western Blot Analysis[2] Cell Line: Rat brain microvascular endothelial cells (RBMECs) Concentration: 0-100 μM Incubation Time: 15 mins, 30 mins, 1 hour, 2 hours, 4 hours Result: Induced RhoA activation and PKB phosphorylation at Ser-473. |
| References |
| Boiling Point | 732ºC at 760 mmHg |
|---|---|
| Melting Point | 175-180°C |
| Molecular Formula | C9H15N5O4S |
| Molecular Weight | 289.311 |
| Flash Point | 396.5ºC |
| Exact Mass | 289.084473 |
| PSA | 146.86000 |
| LogP | 0.72080 |
| Storage condition | −20°C |
| Stability | Light Sensitive - Protect from Light, Store in Freezer |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn:Harmful; |
| Risk Phrases | R22;R36/37/38 |
| Safety Phrases | S26-S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2933599090 |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Molecular biology of the human cytosolic sulfotransferase gene superfamily implicated in the bioactivation of minoxidil and cholesterol in skin.
Exp. Dermatol. 8(4) , 328-9, (1999) Cytosolic sulfotransferases (ST) catalyze the sulfation of various phenolic agents, catecholamines, thyroid hormones, steroids, drugs, and procarcinogens, usually resulting in the inactivation and sub... |
|
|
Iontophoresis-targeted, follicular delivery of minoxidil sulfate for the treatment of alopecia.
J. Pharm. Sci. 102(5) , 1488-94, (2013) Although minoxidil (MX) is a drug known to stimulate hair growth, the treatment of androgenic alopecia could be improved by delivery strategies that would favor drug accumulation into the hair follicl... |
|
|
Sulfation of minoxidil by multiple human cytosolic sulfotransferases.
Chem. Biol. Interact. 109(1-3) , 53-67, (1998) Minoxidil is an antihypertensive agent and hair growth promoter that is metabolized by sulfation to the active compound, minoxidil sulfate. Thermostable phenol sulfotransferase (TS PST or P-PST) was i... |
| ({[2,6-Diamino-4-(1-piperidinyl)pyrimidin-1-ium-1-yl]oxy}sulfonyl)oxidanide |
| Pyrimidinium, 2,6-diamino-4-(1-piperidinyl)-1-(sulfooxy)-, inner salt |
| (2,6-diamino-4-piperidin-1-ylpyrimidin-1-ium-1-yl) sulfate |
| MFCD06248907 |
| Minoxidil sulphate |